...
首页> 外文期刊>Journal of Clinical and Diagnostic Research >Clinical Predictors of Outcome in Buerger?s Disease using BVAS and DEI.Tak Scoring Systems
【24h】

Clinical Predictors of Outcome in Buerger?s Disease using BVAS and DEI.Tak Scoring Systems

机译:使用BVAS和DEI.Tak评分系统对Buerger病结局的临床预测

获取原文
           

摘要

Buerger?s disease is an unclassifiable vasculitis of the small and medium-sized distal arteries and superficial veins. BVAS (Birmingham Vasculitis Activity Score) is a validated disease activity index for vasculitis of different types. DEI.Tak (Disease Extent Index. Takayasu?s arteritis) scoring system is a validated disease extent Index used for Takayasu arteritis.Aim: The aim of this study was to assess outcome in patients with Buerger?s disease using various clinical features, laboratory parameters, BVAS and DEI.Tak scoring system.Materials and Methods: Case records of 136 patients diagnosed with Buerger?s disease in our hospital between August 1996 and July 2006 were studied retrospectively. Various clinical features (smoking history, claudication pain, loss of pulse), laboratory parameters, treatment modalities and outcome measures were recorded in a defined proforma. BVAS and DEI.Tak scoring was done using the data from medical records documented during the patients? last visit to the hospital. Outcome of any patient requiring amputation was considered as bad outcome. Others, who could be managed by antiplatelet drugs, sympathectomy and revascularization procedures without any amputation were classified within the good outcome subset. Statistical analysis was done using Chi-square test and Non parametric MannWhitney test was performed to correlate outcome with all the recorded parameters including those embedded in BVAS and DEI.Tak scoring systems.Results: Sixty eight patients were in each group, namely the good outcome and bad outcome subsets. The mean BVAS score were 10.29±1.26 and 10.88±2.57 and mean DEI.Tak score were 5.29±1.75 and 7.93±2.43 and these scores were observed to be significantly different (p=0.038, p=0.014 respectively) among the good outcome subsets and bad outcome patients with respectively. Proportion of patients with claudication pain and absent upper limb pulse were observed significantly higher in the bad outcome group.Conclusion: Buerger?s disease with higher DEI.Tak score has significantly higher risk of bad outcome. DEI.Tak score can be used as an important predictor of outcome in Buerger?s disease.
机译:布尔格病是中小型远端动脉和浅静脉的无法分类的血管炎。 BVAS(伯明翰血管炎活动评分)是一种针对不同类型血管炎的经过验证的疾病活动指数。 DEI.Tak(疾病程度指数。Takayasu动脉炎)评分系统是用于Takayasu动脉炎的经过验证的疾病程度指数。目的:本研究的目的是使用各种临床方法评估Buerger病患者的预后特征,实验室参数,BVAS和DEI.Tak评分系统。材料与方法:回顾性研究1996年8月至2006年7月间我院诊断为Buerger病的136例患者的病历。在定义的形式中记录了各种临床特征(吸烟史,c行疼痛,脉搏消失),实验室参数,治疗方式和结果指标。使用患者期间记录的病历数据对BVAS和DEI.Tak评分?最后一次去医院。任何需要截肢的患者的结果均被视为不良结果。可以通过抗血小板药物,交感神经切除术和血运重建程序治疗而无需截肢的其他患者则被归类为好结局子集。使用卡方检验和非参数MannWhitney检验进行统计分析,以将结局与所有记录的参数(包括嵌入在BVAS和DEI.Tak评分系统中的参数)相关。结果:每组68例患者,即好结果和坏结果子集。 BVAS平均得分分别为10.29±1.26和10.88±2.57,平均DEI.Tak得分分别为5.29±1.75和7.93±2.43,并且这些结果在好结果子集中有显着差异(分别为p = 0.038,p = 0.014)和不良结局患者。不良结局组中有c行疼痛和上肢无脉搏动的患者比例明显更高。结论:DEI较高的Buerger病。Tak评分的不良结局风险明显较高。 DEI.Tak分数可以用作Buerger病结局的重要预测指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号